41![PRIOR AUTHORIZATION POLICY Cimzia® (certolizumab pegol for subcutaneous [SC] injection [lyophilized] and SC injection [solution] UCB) To Initiate a Coverage Review, Call[removed]OVERVIEW](https://www.pdfsearch.io/img/e16d920fe146edfe53013af49c3b1222.jpg "PRIOR AUTHORIZATION POLICY Cimzia® (certolizumab pegol for subcutaneous [SC] injection [lyophilized] and SC injection [solution] UCB) To Initiate a Coverage Review, Call[removed]OVERVIEW") | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-01-06 13:47:04
|
|---|
42 | Add to Reading ListSource URL: www.cimzia.comLanguage: English - Date: 2013-10-18 08:27:21
|
|---|
43![PRIOR AUTHORIZATION POLICY Kineret® (anakinra for subcutaneous [SC] injection – Biovitrim) To Initiate a Coverage Review, Call[removed]OVERVIEW](https://www.pdfsearch.io/img/f42744c3f5cc2d1062e4676fde2fd767.jpg "PRIOR AUTHORIZATION POLICY Kineret® (anakinra for subcutaneous [SC] injection – Biovitrim) To Initiate a Coverage Review, Call[removed]OVERVIEW") | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-08-12 13:02:40
|
|---|
44 | Add to Reading ListSource URL: kids.phila.govLanguage: English - Date: 2014-07-23 14:19:52
|
|---|
45![PRIOR AUTHORIZATION POLICY Xolair® (omalizumab injection for subcutaneous [SC] use Genentech/Novartis) To Initiate a Coverage Review, Call[removed]](https://www.pdfsearch.io/img/c24d0f8e159397ecfa019a81b7d4775b.jpg "PRIOR AUTHORIZATION POLICY Xolair® (omalizumab injection for subcutaneous [SC] use Genentech/Novartis) To Initiate a Coverage Review, Call[removed]") | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-05-29 15:15:40
|
|---|
46![Report on the Deliberation Results May 31, 2013 Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare [Brand name] Lyxumia Subcutaneous Injection 300 μg](https://www.pdfsearch.io/img/4ac77dd5d2a7b27e1329f2fd351a78b7.jpg "Report on the Deliberation Results May 31, 2013 Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry of Health, Labour and Welfare [Brand name] Lyxumia Subcutaneous Injection 300 μg") | Add to Reading ListSource URL: www.pmda.go.jpLanguage: English - Date: 2014-03-13 00:40:49
|
|---|
47![PRIOR AUTHORIZATION POLICY Simponi™ (golimumab for subcutaneous [SC] injection – Janssen Biotech, Inc.) To Initiate a Coverage Review, Call[removed]OVERVIEW Simponi SC is a recombinant human monoclonal antibod](https://www.pdfsearch.io/img/18c53a89707c782ed5ad5455b7236a36.jpg "PRIOR AUTHORIZATION POLICY Simponi™ (golimumab for subcutaneous [SC] injection – Janssen Biotech, Inc.) To Initiate a Coverage Review, Call[removed]OVERVIEW Simponi SC is a recombinant human monoclonal antibod") | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-08-12 13:02:43
|
|---|
48![PRIOR AUTHORIZATION POLICY Orencia® (abatacept) Subcutaneous [SC] injection: To Initiate a Coverage Review, Call[removed]Intravenous [IV] infusion: To initiate a Coverage Review, Call[removed]OVERVIEW](https://www.pdfsearch.io/img/026a6f057ef067f4fbf57621ae54c14e.jpg "PRIOR AUTHORIZATION POLICY Orencia® (abatacept) Subcutaneous [SC] injection: To Initiate a Coverage Review, Call[removed]Intravenous [IV] infusion: To initiate a Coverage Review, Call[removed]OVERVIEW") | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-08-12 13:02:41
|
|---|
49![PRIOR AUTHORIZATION POLICY Betaseron® and Extavia® (interferon beta-1b for subcutaneous [SC] injection Berlex, Novartis) To Initiate a Coverage Review, Call[removed]](https://www.pdfsearch.io/img/32796f2071305afae6e82cb115fc8c83.jpg "PRIOR AUTHORIZATION POLICY Betaseron® and Extavia® (interferon beta-1b for subcutaneous [SC] injection Berlex, Novartis) To Initiate a Coverage Review, Call[removed]") | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2014-01-29 12:46:47
|
|---|
50 | Add to Reading ListSource URL: www.nmtravelhealth.comLanguage: English - Date: 2008-02-13 23:09:59
|
|---|